37th Annual Meeting Society for Immunotherapy of Cancer (SITC) 2022 – Abstracts

Nov 11, 2022

Abstract Number 1103

Half-life extended, conditionally active IFNa prodrug induces tumor-selective activation and potent antitumor response  


Abstract Number 1191

STRO-003 is a novel ROR1-targeted ADC for breast and lung cancer 


Abstract Number 1359

Half-life extended engineered IL18 variants that escape the negative regulation of IL18BP